+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ocular and systemic pseudoexfoliation syndrome

Ocular and systemic pseudoexfoliation syndrome

American Journal of Ophthalmology 141(5): 921-937

To provide an update on most recent developments regarding ocular and systemic manifestations and complications, clinical diagnosis and management, and molecular pathophysiology of pseudoexfoliation (PEX) syndrome, and to discuss future tasks and challenges in this field. Perspective. Review of recent literature and authors' own clinical and laboratory studies. PEX syndrome is a common age-related generalized fibrotic matrix process of worldwide significance, which may not only cause severe chronic open-angle glaucoma and cataract, but also a spectrum of other serious spontaneous and surgical intraocular complications. Recent progress and advances have led to (1) improvements in clinical management by understanding the effects of the PEX process on ocular tissues, by refining diagnostic criteria, by applying new treatment regimes, and by developing preventive strategies to reduce surgical complications; (2) increasing evidence for systemic associations of PEX with cardiovascular and cerebrovascular morbidity; and (3) new insights into the molecular pathophysiology by analyzing the composition of PEX material, the differential gene expression of affected tissues, and key factors involved in pathogenesis. The current pathogenetic concept describes PEX syndrome as an elastic microfibrillopathy involving transforming growth factor-beta1, oxidative stress, and impaired cellular protection mechanisms as key pathogenetic factors. Future tasks and challenges comprise epidemiologic prevalence and genetic studies of PEX syndrome, prospective randomized clinical and histopathological screening studies on its systemic manifestations and associations, and intensified basic research on differential protein and gene expression, animal and in vitro models, as well as potential biomarkers for PEX syndrome and its associated glaucoma.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 049742573

Download citation: RISBibTeXText

PMID: 16678509

DOI: 10.1016/j.ajo.2006.01.047

Related references

Ocular and Systemic Pseudoexfoliation Syndrome. Yearbook of Ophthalmology 2007: 244-246, 2007

Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder?. Archives of Ophthalmology 110(12): 1752-1756, 1992

Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations. Human Genomics 6: 22, 2012

Prevalence of pseudoexfoliation syndrome and its association with ocular and systemic diseases in Eskisehir, Turkey. International Journal of Ophthalmology 10(1): 128-134, 2017

Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Ophthalmology 108(6): 1043-1049, 2001

Systemic high-sensitivity C-reactive protein level in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Journal of Glaucoma 19(6): 373-376, 2010

Pseudoexfoliation: An Ocular Finding with Possible Systemic Implications. Israel Medical Association Journal 19(1): 49-54, 2017

Ocular pseudoexfoliation syndrome. Medicinski Pregled 63(9-10): 681-688, 2011

Ocular pseudoexfoliation syndrome. Medicinski pregled 63(9-10): 681-688, 2010

Plateletcrit in Ocular Pseudoexfoliation Syndrome. Eye and Contact Lens 42(5): 328-332, 2016

Pseudoexfoliation of the lens capsule part 3 ocular tension in eyes with pseudoexfoliation. Acta Ophthalmologica: 446-454, 1970

Pseudoexfoliation of the lens capsule. 3. Ocular tension in eyes with pseudoexfoliation. Acta Ophthalmologica 48(3): 446-454, 1970

Ocular Pseudoexfoliation Syndrome and Life Span: Act 2. Ebiomedicine 2(7): 640-641, 2015

Ocular blood flow in pseudoexfoliation syndrome. Investigative Ophthalmology & Visual Science 37(3): S31, 1996

Ocular pseudoexfoliation syndrome and life span. Ebiomedicine 2(7): 765-769, 2015